Corynebacterium jeikeium: Difference between revisions
From IDWiki
Corynebacterium jeikeium
No edit summary |
No edit summary |
||
| Line 83: | Line 83: | ||
|[[Nitrofurantoin]] |
|[[Nitrofurantoin]] |
||
|76 |
|76 |
||
| − | |ND |
||
| − | |} |
||
| − | {| class="wikitable" |
||
| − | | |
||
| − | | |
||
| − | | |
||
| − | | |
||
| − | | |
||
| − | | |
||
| − | |- |
||
| − | |Penicillin |
||
| − | |76 |
||
| − | |0.5 to >8 |
||
| − | |>8 |
||
| − | |>8 |
||
| − | |0 |
||
| − | |- |
||
| − | | Ampicillin |
||
| − | |76 |
||
| − | |≤0.12 to >8 |
||
| − | |>8 |
||
| − | |>8 |
||
| − | |ND |
||
| − | |- |
||
| − | | Oxacillin |
||
| − | |76 |
||
| − | |0.5 to >4 |
||
| − | |>4 |
||
| − | |>4 |
||
| − | |ND |
||
| − | |- |
||
| − | | Erythromycin |
||
| − | |76 |
||
| − | |≤0.25 to >4 |
||
| − | |>4 |
||
| − | |>4 |
||
| − | |11.8 |
||
| − | |- |
||
| − | | Clindamycin |
||
| − | |76 |
||
| − | |≤0.5 to >2 |
||
| − | |>2 |
||
| − | |>2 |
||
| − | |2.6 |
||
| − | |- |
||
| − | | Ciprofloxacin |
||
| − | |75 |
||
| − | |≤1 to >2 |
||
| − | |>2 |
||
| − | |>2 |
||
| − | |35.5 |
||
| − | |- |
||
| − | | Levofloxacin |
||
| − | |75 |
||
| − | |≤0.25 to >4 |
||
| − | |>4 |
||
| − | |>4 |
||
| − | |ND |
||
| − | |- |
||
| − | | Moxifloxacin<sup>''b''</sup> |
||
| − | |76 |
||
| − | |≤0.25 to >4 |
||
| − | |4 |
||
| − | |>4 |
||
| − | |35.5 |
||
| − | |- |
||
| − | | Tetracycline |
||
| − | |76 |
||
| − | |≤2 to >16 |
||
| − | |≤2 |
||
| − | |≤2 |
||
| − | |92.1 |
||
| − | |- |
||
| − | | Vancomycin |
||
| − | |76 |
||
| − | |≤0.25 to 2 |
||
| − | |0.50 |
||
| − | |1 |
||
| − | |100 |
||
| − | |- |
||
| − | | Trimethoprim-sulfamethoxazole |
||
| − | |76 |
||
| − | |≤0.5 to >4 |
||
| − | |>4 |
||
| − | |>4 |
||
| − | |18.4 |
||
| − | |- |
||
| − | | Tigecycline |
||
| − | |76 |
||
| − | |≤0.03 to >0.5 |
||
| − | |0.12 |
||
| − | |0.25 |
||
| − | |ND |
||
| − | |- |
||
| − | | Rifampin |
||
| − | |76 |
||
| − | |≤0.5 to >4 |
||
| − | |≤0.5 |
||
| − | |≤0.5 |
||
| − | |97.4 |
||
| − | |- |
||
| − | | Quinupristin-dalfopristin |
||
| − | |76 |
||
| − | |≤0.5 to 4 |
||
| − | |≤0.5 |
||
| − | |2 |
||
| − | |89.5 |
||
| − | |- |
||
| − | | Linezolid |
||
| − | |76 |
||
| − | |≤1 |
||
| − | |≤1 |
||
| − | |≤1 |
||
| − | |100 |
||
| − | |- |
||
| − | | Gentamicin |
||
| − | |76 |
||
| − | |≤2 to >16 |
||
| − | |≤2 |
||
| − | |>16 |
||
| − | |81.6 |
||
| − | |- |
||
| − | | Daptomycin |
||
| − | |75 |
||
| − | |≤0.5 to >4 |
||
| − | |≤0.5 |
||
| − | |1 |
||
| − | |89.5 |
||
| − | |- |
||
| − | | Chloramphenicol |
||
| − | |75 |
||
| − | |≤2 to >16 |
||
| − | |4 |
||
| − | |16 |
||
| − | |ND |
||
| − | |- |
||
| − | | Nitrofurantoin |
||
| − | |76 |
||
| − | |≤32 to >64 |
||
| − | |>64 |
||
| − | |>64 |
||
|ND |
|ND |
||
|} |
|} |
||
Revision as of 10:37, 27 September 2023
- Species of Corynebacterium that causes opportunistic infections, most closely associated with hematologic stem cell transplant patients
- Clinical presentations include bacteremia, prosthetic valve endocarditis, meningitis, and peritonitis
- Essentially universally susceptible to vancomycin and linezolid
- High rates of resistance to beta lactams; may be fluoroquinolone or tetracycline susceptible[1]
| Antibiotic | Isolates | % Susceptible |
|---|---|---|
| Penicillin | 76 | 0 |
| Ampicillin | 76 | ND |
| Oxacillin | 76 | ND |
| Erythromycin | 76 | 11.8 |
| Clindamycin | 76 | 2.6 |
| Ciprofloxacin | 75 | 35.5 |
| Levofloxacin | 75 | ND |
| Moxifloxacin | 76 | 35.5 |
| Tetracycline | 76 | 92.1 |
| Vancomycin | 76 | 100 |
| Trimethoprim-sulfamethoxazole | 76 | 18.4 |
| Tigecycline | 76 | ND |
| Rifampin | 76 | 97.4 |
| Quinupristin-dalfopristin | 76 | 89.5 |
| Linezolid | 76 | 100 |
| Gentamicin | 76 | 81.6 |
| Daptomycin | 75 | 89.5 |
| Chloramphenicol | 75 | ND |
| Nitrofurantoin | 76 | ND |
- ↑ 1.0 1.1 Neemuchwala A, Soares D, Ravirajan V, Marchand-Austin A, Kus JV, Patel SN. In Vitro Antibiotic Susceptibility Pattern of Non-diphtheriae Corynebacterium Isolates in Ontario, Canada, from 2011 to 2016. Antimicrob Agents Chemother. 2018 Mar 27;62(4):e01776-17. doi: 10.1128/AAC.01776-17. PMID: 29339389; PMCID: PMC5914010.
